263 related articles for article (PubMed ID: 30974132)
1. Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set.
Wolfe CE; Wood DM; Dines A; Whatley BP; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Dargan PI;
Neurotoxicology; 2019 Jul; 73():183-187. PubMed ID: 30974132
[TBL] [Abstract][Full Text] [Related]
2. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
[TBL] [Abstract][Full Text] [Related]
3. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019.
Crulli B; Dines AM; Blanco G; Giraudon I; Eyer F; Liechti ME; Miró Ò; Hovda KE; Heyerdahl F; Yates C; Vallersnes OM; Wood DM; Dargan PI;
Clin Toxicol (Phila); 2022 Dec; 60(12):1318-1327. PubMed ID: 36322684
[TBL] [Abstract][Full Text] [Related]
4. Psychosis associated with acute recreational drug toxicity: a European case series.
Vallersnes OM; Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Dargan PI
BMC Psychiatry; 2016 Aug; 16():293. PubMed ID: 27538886
[TBL] [Abstract][Full Text] [Related]
5. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
[TBL] [Abstract][Full Text] [Related]
6. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
[TBL] [Abstract][Full Text] [Related]
7. Emergence of new classes of recreational drugs-synthetic cannabinoids and cathinones.
Khullar V; Jain A; Sattari M
J Gen Intern Med; 2014 Aug; 29(8):1200-4. PubMed ID: 24553958
[TBL] [Abstract][Full Text] [Related]
8. Emergencies related to recreational drug abuse in Spain compared to emergencies attended in 3 European areas.
Miró Ò; Yates C; Dines AM; Wood DM; Dargan PI; Galán I; Jerez A; Puiguriguer J; Waring WS; Moughty A; O'Connor N; Heyerdahl F; Hovda KE; Vallersnes OM; Paasma R; Põld K; Jürgens G; Megarbane B; Anand JS; Liakoni E; Liechti M; Eyer F; Zacharov S; Caganova B; Giraudon I; Galicia M
Emergencias; 2018 Dic; 30(6):385-394. PubMed ID: 30638341
[TBL] [Abstract][Full Text] [Related]
9. Rhabdomyolysis related to acute recreational drug toxicity-A Euro-DEN study.
Waldman W; Kabata PM; Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Dargan PI; Sein Anand J
PLoS One; 2021; 16(3):e0246297. PubMed ID: 33705425
[TBL] [Abstract][Full Text] [Related]
10. Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on European emergency departments.
Miró Ò; Waring WS; Dargan PI; Wood DM; Dines AM; Yates C; Giraudon I; Moughty A; O'Connor N; Heyerdahl F; Hovda KE; Vallersnes OM; Paasma R; Pold K; Jürgens G; Megarbane B; Anand JS; Liakoni E; Liechti M; Eyer F; Zacharov S; Caganova B; Bonnici J; Radenkova-Saeva J; Galicia M;
Clin Toxicol (Phila); 2021 Oct; 59(10):896-904. PubMed ID: 33724118
[TBL] [Abstract][Full Text] [Related]
11. Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity.
Liakoni E; Müller S; Stoller A; Ricklin M; Liechti ME; Exadaktylos AK
Scand J Trauma Resusc Emerg Med; 2017 Mar; 25(1):26. PubMed ID: 28264690
[TBL] [Abstract][Full Text] [Related]
12. Clinical effects of cannabis compared to synthetic cannabinoid receptor agonists (SCRAs): a retrospective cohort study of presentations with acute toxicity to European hospitals between 2013 and 2020.
Waters ML; Dargan PI; Yates C; Dines AM; Eyer F; Giraudon I; Heyerdahl F; Hovda KE; Liechti ME; Miró Ò; Vallersnes OM; Anseeuw K; Badaras R; Bitel M; Bonnici J; Brvar M; Caganova B; Calýskan F; Ceschi A; Chamoun K; Daveloose L; Galicia M; Gartner B; Gorozia K; Grenc D; Gresnigt FMJ; Hondebrink L; Jürgens G; Konstari J; Kutubidze S; Laubner G; Liakoni E; Liguts V; Lyphout C; McKenna R; Mégarbane B; Moughty A; Nitescu GV; Noseda R; O'Connor N; Paasma R; Ortega Perez J; Perminas M; Persett PS; Põld K; Puchon E; Puiguriguer J; Radenkova-Saeva J; Rulisek J; Samer C; Schmid Y; Scholz I; Stašinskis R; Surkus J; Van den Hengel-Koot I; Vigorita F; Vogt S; Waldman W; Waring WS; Zacharov S; Zellner T; Wood DM
Clin Toxicol (Phila); 2024 Jun; ():1-7. PubMed ID: 38934347
[TBL] [Abstract][Full Text] [Related]
13. Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series.
Liakoni E; Dolder PC; Rentsch KM; Liechti ME
BMC Pharmacol Toxicol; 2016 May; 17(1):25. PubMed ID: 27228985
[TBL] [Abstract][Full Text] [Related]
14. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
16. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population.
Kimergård A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537
[TBL] [Abstract][Full Text] [Related]
17. New and Emerging Illicit Psychoactive Substances.
Graddy R; Buresh ME; Rastegar DA
Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
[TBL] [Abstract][Full Text] [Related]
18. An index of fatal toxicity for new psychoactive substances.
King LA; Corkery JM
J Psychopharmacol; 2018 Jul; 32(7):793-801. PubMed ID: 29482434
[TBL] [Abstract][Full Text] [Related]
19. The other side of the leaf: Seizures associated with synthetic cannabinoid use.
Gounder K; Dunuwille J; Dunne J; Lee J; Silbert P; Lawn N
Epilepsy Behav; 2020 Mar; 104(Pt A):106901. PubMed ID: 31958643
[TBL] [Abstract][Full Text] [Related]
20. New Psychoactive Substances in Pediatric Patients.
Warrick BJ; Tataru AP; Gerona R
Pediatr Clin North Am; 2017 Dec; 64(6):1223-1241. PubMed ID: 29173782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
